This marks the first time two CNCO members are collaborating after amicably breaking ties in 2022. By Jessica Roiz Assistant Editor, Latin CNCOwners, rejoice! Erick Brian and Christopher Vélez have ...
Tanner Cero turns on a small lamp that barely registers to the naked eye but adds just the right amount of illumination to the green screen that backdrops his bedroom wall. Tanner, 15, is now suited ...
MILAN--(BUSINESS WIRE)--As the 100-day countdown to the Olympic Winter Games continues, and in a year the global Corona brand is celebrating its 100 th anniversary, Corona Cero is officially set to ...
Trading of the Company's shares of common stock on Nasdaq will be suspended at the open of trading on October 31 CERo plans to appeal the Panel determination, seek trading of its shares on the OTC ...
Regulatory milestone adds to its existing Orphan Drug Designation, creating additional regulatory and financial advantages for the Company’s lead cancer immunotherapy program “These FDA designations ...
CERo Therapeutics Holdings, Inc. is an immunotherapy company advancing the development of engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, ...
SOUTH SAN FRANSCISCO, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance the ...
Whether it was in AAA, CMLL, Lucha Underground, the independent scene, TNA, AEW, or now WWE, there's always been one constant about Penta's career; "Cero Miedo". It's connected to him in a way that ...
Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community. Issues are used to track todos, bugs, feature requests, and more.
Penta is one of the most popular WWE Superstars at the moment, making an immediate impact following his debut on January 13. His catchphrase, "Cero Miedo" has also been over with the fans along with ...
CERo Therapeutics (CERO) stock soared on Monday as investors reacted to the latest preclinical data from the immunotherapy company. This covers its lead compound, CER-1236, and its ability to kill ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results